TY - JOUR AU - Coates, A. S. AU - Keshaviah, A. AU - Thurlimann, B. PY - 2007 DA - 2007// TI - Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1–98 JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.08.8617 DO - 10.1200/JCO.2006.08.8617 ID - Coates2007 ER - TY - JOUR AU - Forbes, J. F. AU - Cuzick, J. AU - Buzdar, A. AU - Howell, A. AU - Tobias, J. S. AU - Baum, M. PY - 2008 DA - 2008// TI - Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial JO - Lancet Oncol VL - 9 UR - https://doi.org/10.1016/S1470-2045(07)70385-6 DO - 10.1016/S1470-2045(07)70385-6 ID - Forbes2008 ER - TY - JOUR AU - Howell, A. AU - Cuzick, J. AU - Baum, M. PY - 2005 DA - 2005// TI - Result.s of the ATAC (arimidex, tamoxifen, alone or in combination) trial after completion of 5 years’ adjuvant treatment for breast cancer JO - Lancet VL - 365 UR - https://doi.org/10.1016/S0140-6736(05)74803-0 DO - 10.1016/S0140-6736(05)74803-0 ID - Howell2005 ER - TY - JOUR AU - Santen, R. J. AU - Demers, L. AU - Ohorodnik, S. AU - Settlage, J. AU - Langecker, P. AU - Blanchett, D. AU - Goss, P. E. AU - Wang, S. PY - 2007 DA - 2007// TI - Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy JO - Steroids VL - 72 UR - https://doi.org/10.1016/j.steroids.2007.05.003 DO - 10.1016/j.steroids.2007.05.003 ID - Santen2007 ER - TY - JOUR AU - Stanczyk, F. Z. AU - Clarke, N. J. PY - 2010 DA - 2010// TI - Advantages and challenges of mass spectrometry assays for steroid hormones JO - J Steroid Biochem Mol Biol VL - 121 UR - https://doi.org/10.1016/j.jsbmb.2010.05.001 DO - 10.1016/j.jsbmb.2010.05.001 ID - Stanczyk2010 ER - TY - JOUR AU - Stanczyk, F. Z. AU - Jurow, J. AU - Hsing, A. W. PY - 2010 DA - 2010// TI - Limitations of direct immunoassays for measuring circulating estradiol levels in postmenopausal women and men in epidemiologic studies JO - Cancer Epidemiol Biomark Prev VL - 19 UR - https://doi.org/10.1158/1055-9965.EPI-10-0081 DO - 10.1158/1055-9965.EPI-10-0081 ID - Stanczyk2010 ER - TY - JOUR AU - Stanczyk, F. Z. AU - Cho, M. M. AU - Endres, D. B. AU - Morrison, J. L. AU - Patel, S. AU - Paulson, R. J. PY - 2003 DA - 2003// TI - Limitations of direct estradiol and testosterone immunoassay kits JO - Steroids VL - 68 UR - https://doi.org/10.1016/j.steroids.2003.08.012 DO - 10.1016/j.steroids.2003.08.012 ID - Stanczyk2003 ER - TY - JOUR AU - Amir, E. AU - Seruga, B. AU - Niraula, S. AU - Carlsson, L. AU - Ocaña, A. PY - 2011 DA - 2011// TI - Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis JO - J Natl Cancer Inst VL - 103 UR - https://doi.org/10.1093/jnci/djr242 DO - 10.1093/jnci/djr242 ID - Amir2011 ER - TY - JOUR AU - Dowsett, M. AU - Cuzick, J. AU - Ingle, J. PY - 2010 DA - 2010// TI - Meta-analysis of breast cancer outcomes in adjuvant trials for aromatase inhibitors versus tamoxifen JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.23.1274 DO - 10.1200/JCO.2009.23.1274 ID - Dowsett2010 ER -